Header Logo

Connection

JULIE GASTIER-FOSTER to Infant

Back to Details
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Infant.
JULIE GASTIER-FOSTER
Connection Strength
0.672
Infant
  1. Expanding the spectrum of CEP55-associated disease to viable phenotypes. Am J Med Genet A. 2020 05; 182(5):1201-1208.
    View in: PubMed
    Score: 0.058
  2. Unexpected detection of dystrophin gene deletions by array comparative genomic hybridization. Am J Med Genet A. 2010 Sep; 152A(9):2301-7.
    View in: PubMed
    Score: 0.030
  3. Pediatric Malignant Tumors in Malawi: A Diagnostic Report From the Kamuzu Central Hospital Pathology Laboratory 2011-2020. Pediatr Blood Cancer. 2025 Jul; 72(7):e31669.
    View in: PubMed
    Score: 0.021
  4. Outcomes of patients with intermediate-risk neuroblastoma presenting with motor deficits relating to intraspinal tumor extension: A report from the Children's Oncology Group study ANBL0531. Pediatr Blood Cancer. 2025 Jan; 72(1):e31407.
    View in: PubMed
    Score: 0.020
  5. Long-term follow-up of patients with intermediate-risk neuroblastoma treated with response- and biology-based therapy: A report from the Children's Oncology Group study ANBL0531. Pediatr Blood Cancer. 2024 Aug; 71(8):e31089.
    View in: PubMed
    Score: 0.019
  6. Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group. J Clin Oncol. 2024 Jan 10; 42(2):218-227.
    View in: PubMed
    Score: 0.019
  7. Stage 4S Neuroblastoma: Molecular, Histologic, and Immunohistochemical Characteristics and Presence of 2 Distinct Patterns of MYCN Protein Overexpression-A Report From the Children's Oncology Group. Am J Surg Pathol. 2021 08 01; 45(8):1075-1081.
    View in: PubMed
    Score: 0.016
  8. Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group. J Clin Oncol. 2021 10 10; 39(29):3229-3241.
    View in: PubMed
    Score: 0.016
  9. Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident. Science. 2021 05 14; 372(6543).
    View in: PubMed
    Score: 0.016
  10. Favorable Trisomies and ETV6-RUNX1 Predict Cure in Low-Risk B-Cell Acute Lymphoblastic Leukemia: Results From Children's Oncology Group Trial AALL0331. J Clin Oncol. 2021 05 10; 39(14):1540-1552.
    View in: PubMed
    Score: 0.016
  11. Diverse deletions in the growth hormone receptor gene cause growth hormone insensitivity syndrome. Hum Mutat. 2000 Oct; 16(4):323-33.
    View in: PubMed
    Score: 0.015
  12. Genetic Characterization of Pediatric Sarcomas by Targeted RNA Sequencing. J Mol Diagn. 2020 10; 22(10):1238-1245.
    View in: PubMed
    Score: 0.015
  13. Association of heterogeneous MYCN amplification with clinical features, biological characteristics?and outcomes in neuroblastoma: A report from the Children's Oncology Group. Eur J Cancer. 2020 07; 133:112-119.
    View in: PubMed
    Score: 0.015
  14. Homozygous variants in AMPD2 and COL11A1 lead to a complex phenotype of pontocerebellar hypoplasia type 9 and Stickler syndrome type 2. Am J Med Genet A. 2020 03; 182(3):557-560.
    View in: PubMed
    Score: 0.014
  15. Outcome in Children With Standard-Risk B-Cell Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0331. J Clin Oncol. 2020 02 20; 38(6):602-612.
    View in: PubMed
    Score: 0.014
  16. Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. J Clin Oncol. 2019 12 01; 37(34):3243-3255.
    View in: PubMed
    Score: 0.014
  17. PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia. Nat Genet. 2019 02; 51(2):296-307.
    View in: PubMed
    Score: 0.013
  18. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma. Blood. 2019 03 21; 133(12):1313-1324.
    View in: PubMed
    Score: 0.013
  19. Improved Survival for Children and Young Adults With T-Lineage Acute Lymphoblastic Leukemia: Results From the Children's Oncology Group AALL0434 Methotrexate Randomization. J Clin Oncol. 2018 10 10; 36(29):2926-2934.
    View in: PubMed
    Score: 0.013
  20. Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group. Blood. 2018 08 23; 132(8):815-824.
    View in: PubMed
    Score: 0.013
  21. Dasatinib Plus Intensive Chemotherapy in Children, Adolescents, and Young Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of Children's Oncology Group Trial AALL0622. J Clin Oncol. 2018 08 01; 36(22):2306-2314.
    View in: PubMed
    Score: 0.013
  22. Flow-cytometric vs. -morphologic assessment of remission in childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group (COG). Leukemia. 2018 06; 32(6):1370-1379.
    View in: PubMed
    Score: 0.013
  23. Isolated late testicular relapse of B-cell acute lymphoblastic leukemia treated with intensive systemic chemotherapy and response-based testicular radiation: A Children's Oncology Group study. Pediatr Blood Cancer. 2018 05; 65(5):e26928.
    View in: PubMed
    Score: 0.012
  24. Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group. Cancer. 2017 Nov 01; 123(21):4224-4235.
    View in: PubMed
    Score: 0.012
  25. Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2017 Dec; 64(12).
    View in: PubMed
    Score: 0.012
  26. Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children's Oncology Group Study AALL0232. J Clin Oncol. 2016 07 10; 34(20):2380-8.
    View in: PubMed
    Score: 0.011
  27. Histology, Fusion Status, and Outcome in Alveolar Rhabdomyosarcoma With Low-Risk Clinical Features: A Report From the Children's Oncology Group. Pediatr Blood Cancer. 2016 Apr; 63(4):634-9.
    View in: PubMed
    Score: 0.011
  28. A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia. Acta Paediatr. 2016 Apr; 105(4):e170-5.
    View in: PubMed
    Score: 0.011
  29. Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies. Pediatr Blood Cancer. 2016 Feb; 63(2):255-61.
    View in: PubMed
    Score: 0.011
  30. Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2015 Oct 15; 21(20):4733-9.
    View in: PubMed
    Score: 0.011
  31. Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet. 2015 08; 47(8):864-71.
    View in: PubMed
    Score: 0.010
  32. Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested? Bone Marrow Transplant. 2015 Sep; 50(9):1173-9.
    View in: PubMed
    Score: 0.010
  33. IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients. Blood. 2015 May 28; 125(22):3501-8.
    View in: PubMed
    Score: 0.010
  34. Safe integration of nelarabine into intensive chemotherapy in newly diagnosed T-cell acute lymphoblastic leukemia: Children's Oncology Group Study AALL0434. Pediatr Blood Cancer. 2015 Jul; 62(7):1176-83.
    View in: PubMed
    Score: 0.010
  35. Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. J Clin Oncol. 2014 Dec 01; 32(34):3874-82.
    View in: PubMed
    Score: 0.010
  36. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014 Sep 11; 371(11):1005-15.
    View in: PubMed
    Score: 0.010
  37. Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group. Pediatr Dev Pathol. 2014 Nov-Dec; 17(6):441-9.
    View in: PubMed
    Score: 0.010
  38. Atypical breakpoint in a t(6;17) translocation case of acampomelic campomelic dysplasia. Eur J Med Genet. 2014 Jul; 57(7):315-8.
    View in: PubMed
    Score: 0.010
  39. The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial. Blood. 2014 Mar 27; 123(13):2017-25.
    View in: PubMed
    Score: 0.010
  40. Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group. Cancer. 2013 Oct 15; 119(20):3718-26.
    View in: PubMed
    Score: 0.009
  41. A case of an atypically large proximal 15q deletion as cause for Prader-Willi syndrome arising from a de novo unbalanced translocation. Eur J Med Genet. 2013 Sep; 56(9):510-4.
    View in: PubMed
    Score: 0.009
  42. PAX-FOXO1 fusion status drives unfavorable outcome for children with rhabdomyosarcoma: a children's oncology group report. Pediatr Blood Cancer. 2013 Sep; 60(9):1411-7.
    View in: PubMed
    Score: 0.009
  43. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus. Am J Hum Genet. 2013 Feb 07; 92(2):210-20.
    View in: PubMed
    Score: 0.009
  44. Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. Pediatr Blood Cancer. 2013 Mar; 60(3):363-70.
    View in: PubMed
    Score: 0.009
  45. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group. Genes Chromosomes Cancer. 2012 Jul; 51(7):662-74.
    View in: PubMed
    Score: 0.008
  46. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study. Blood. 2012 Apr 12; 119(15):3512-22.
    View in: PubMed
    Score: 0.008
  47. Locoregional MYCN-amplified neuroblastoma. Pediatr Blood Cancer. 2012 Oct; 59(4):736-8.
    View in: PubMed
    Score: 0.008
  48. Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 2011 Jul 14; 118(2):243-51.
    View in: PubMed
    Score: 0.008
  49. Identification of a recurrent microdeletion at 17q23.1q23.2 flanked by segmental duplications associated with heart defects and limb abnormalities. Am J Hum Genet. 2010 Mar 12; 86(3):454-61.
    View in: PubMed
    Score: 0.007
  50. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG. Pediatr Blood Cancer. 2009 Oct; 53(4):563-9.
    View in: PubMed
    Score: 0.007
  51. Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome. Am J Med Genet. 2000 Feb 28; 90(5):390-7.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.